Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study

被引:18
|
作者
Larsen, Rikke Faebo [1 ,2 ,3 ]
Jarden, Mary [4 ,5 ]
Minet, Lisbeth Rosenbek [2 ,6 ,7 ]
Frolund, Ulf Christian [8 ]
Moeller, Soeren [2 ]
Abildgaard, Niels [2 ,9 ,10 ]
机构
[1] Zealand Univ Hosp, Dept Physiotherapy & Occupat Therapy, Roskilde, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Odense Univ Hosp, OPEN, Open Patient Data Explorat Network, Odense, Denmark
[4] Copenhagen Univ Hosp, Dept Haematol, Rigshosp, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark
[6] Odense Univ Hosp, Dept Rehabil, Odense, Denmark
[7] UCL Univ Coll, Hlth Sci Res Ctr, Odense, Denmark
[8] Zealand Univ Hosp, Dept Haematol, Roskilde, Denmark
[9] Odense Univ Hosp, Dept Haematol, Odense, Denmark
[10] Odense Univ Hosp, Acad Geriatr Canc Res AgeCare, Odense, Denmark
关键词
Multiple myeloma; Bone disease; Physical function; Reference values; Cross sectional; QUALITY-OF-LIFE; ANDROGEN-DEPRIVATION THERAPY; MUSCLE STRENGTH; OLDER-ADULTS; WALK TEST; EXERCISE; CANCER; FITNESS; VALIDITY; CHEMOTHERAPY;
D O I
10.1186/s12885-020-6637-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMultiple myeloma is a cancer in the bone marrow causing bone destruction. Patients experience various symptoms related to the disease and/or treatment, such as pain and fatigue, leading to poorer quality of life. The symptom burden might affect physical function and physical activity levels, posing a risk of physical deterioration. The aim was to investigate whether physical function in newly diagnosed patients with multiple myeloma differs from the reference values of the normal population and other cancer patients.MethodsThe study is a cross sectional descriptive analysis of a prospective cohort of 100 patients newly diagnosed with multiple myeloma. Four physical function tests were carried out; Six-Minute-Walk-Test, Sit-to-Stand-Test, grip strength and knee extension strength. Age and gender specific results of physical function from the multiple myeloma population were compared to normative data and to data from other cancer populations.ResultsOf the 100 patients included, 73% had bone disease and 55% received pain relieving medicine. Mean age was 67.7years (SD 10.3). Patients with multiple myeloma had significantly poorer physical function compared to normative data, both regarding aerobic capacity and muscle strength, although not grip strength. No differences in physical function were found between patients with multiple myeloma and other cancer populations.ConclusionsPhysical function in newly diagnosed Danish patients with multiple myeloma is lower than in the normal population. Exercise intervention studies are warranted to explore the value of physical exercise on physical function.Trial registrationClinicalTrials.gov, ID NCT02439112, registered 8 May 2015.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy
    Askman, Sandra
    Westerlund, Julia
    Pettersson, Asa
    Hellmark, Thomas
    Johansson, Asa
    Wichert, Stina
    Hansson, Markus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (01) : 72 - 81
  • [22] MANAGEMENT OF OCTOGENARIAN AND FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA, A REALWORLD STUDY
    Gambara, S.
    Poletti, A.
    La Greca, O.
    Cuneo, A.
    Sessa, M.
    HAEMATOLOGICA, 2024, 109 : 113 - 114
  • [23] Exercise in Patients Newly Diagnosed with Multiple Myeloma - a Randomized Controlled Feasibility Study
    Larsen, Rikke F.
    Jarden, Mary
    Minet, Lisbeth R.
    Frolund, Ulf C.
    Abildgaard, Niels
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2019, 51 (06): : 428 - 428
  • [24] The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma
    Yang, Peiyu
    Zhou, Fan
    Dong, Yujun
    Gao, Guangxun
    Xue, Hua
    Liang, Xinyue
    Yu, Shanshan
    Xu, Weiling
    Ma, Yanping
    Qin, Xiaoqi
    Li, Mengyao
    Dai, Yun
    Jin, Fengyan
    BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [25] The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
    Yang, Peiyu
    Zhou, Fan
    Dong, Yujun
    Gao, Guangxun
    Xue, Hua
    Liang, Xinyue
    Yu, Shanshan
    Xu, Weiling
    Ma, Yanping
    Qin, Xiaoqi
    Li, Mengyao
    Dai, Yun
    Jin, Fengyan
    HEMASPHERE, 2023, 7 (04):
  • [26] The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma
    Peiyu Yang
    Fan Zhou
    Yujun Dong
    Guangxun Gao
    Hua Xue
    Xinyue Liang
    Shanshan Yu
    Weiling Xu
    Yanping Ma
    Xiaoqi Qin
    Mengyao Li
    Yun Dai
    Fengyan Jin
    Blood Cancer Journal, 12
  • [27] RENAL-FUNCTION IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA - A DEMOGRAPHIC-STUDY OF 1353 PATIENTS
    KNUDSEN, LM
    HIPPE, E
    HJORTH, M
    HOLMBERG, E
    WESTIN, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1994, 53 (04) : 207 - 212
  • [28] Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study
    Mohyuddin, Ghulam Rehman
    Mian, Hira
    Gayowsky, Anastasia
    Seow, Hsien
    Chakraborty, Rajshekhar
    Pond, Gregory R.
    Al Hadidi, Samer
    Visram, Alissa
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [29] Monoclonal Protein Response Trajectory and Survival in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort Study
    Bi, Jayce
    Lambert, Pascal
    Houston, Brett L.
    Minuk, Leonard A.
    Dao, Vi
    Kotb, Rami
    Houston, Donald S.
    Zarychanski, Ryan
    Rimmer, Emily
    BLOOD, 2020, 136
  • [30] Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
    Sorrig, Rasmus
    Klausen, Tobias W.
    Salomo, Morten
    Vangsted, Annette J.
    Frolund, Ulf Christian
    Andersen, Kristian T.
    Klostergaard, Anja
    Helleberg, Carsten
    Pedersen, Robert S.
    Pedersen, Per T.
    Helm-Petersen, Sissel
    Teodorescu, Elena Manuela
    Preiss, Birgitte
    Abildgaard, Niels
    Gimsing, Peter
    PLOS ONE, 2017, 12 (12):